COVID-19 Virtual Care at Home
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04420182|
Recruitment Status : Recruiting
First Posted : June 9, 2020
Last Update Posted : December 8, 2020
This multicentre prospective cohort trial is designed to demonstrate effectiveness and efficiency of a virtual care model for the management of COVID-19 patients isolating at home. The investigators have reoriented existing technology and networks for this research project. The investigators are amplifying our existing virtual care platform VIRTUES, combining it with home monitoring of COVID-19 patients, to provide real-time evidence, harmonize data collection, and share data provincially to mitigate the impact of the rapid spread of the virus. The study will facilitate early detection of complications associated with the disease, treatment and management of COVID-19 patients at home. The research will be conducted provincially in Ontario.
This initiative will provide evidence to inform clinical and health system management and public health response to COVID-19 patients isolating at home.
|Condition or disease||Intervention/treatment||Phase|
|Covid-19||Other: Virtual Care at Home||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||2000 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||Prospective non-randomized cohort study|
|Masking:||None (Open Label)|
|Official Title:||COVID-19 Virtual Care at Home|
|Actual Study Start Date :||August 17, 2020|
|Estimated Primary Completion Date :||June 30, 2021|
|Estimated Study Completion Date :||December 31, 2021|
COVID-19 Virtual Care at Home
VIRTUES COVID-19 Care at Home Platform
The components of the platform will include:
Other: Virtual Care at Home
Participants will have access to the VIRTUES platform for COVID-19 Virtual Care at Home
- 14 Day Patient Satisfaction Questionnaire [ Time Frame: 14 days ]The primary outcome measure is patient satisfaction as measured from a patient satisfaction questionnaire at 14 days.
- Emergency Department Visits [ Time Frame: 14 days ]The secondary outcome measures will include the number of patients that require an Emergency Department visits during the observation period of 14 days.
- 14 Day EQ-5D-5L Scores [ Time Frame: 14 days ]The secondary outcome measures will include the health status measures of the EuroQuality of Life Five Dimensions (EQ-5D-5L) at 14 days. Scoring is Level 1 to 5 for each dimension; higher scores meaning worse health status.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04420182
|Contact: Anthony Tang, MDemail@example.com|
|Contact: Rachel Carisfirstname.lastname@example.org|
|St. Mary's General Hospital||Recruiting|
|Kitchener, Ontario, Canada|
|Contact: Mary Radyk, RN 519-749-6578 ext 2503 email@example.com|
|Principal Investigator: Sindu Mohan, MD|
|London Health Sciences Centre||Recruiting|
|London, Ontario, Canada, N6A5A5|
|Contact: Marko Mrkobrada, MD 519-685-8500|
|Principal Investigator: Marko Mrkobrada, MD|
|Ottawa Heart Research Institute||Recruiting|
|Ottawa, Ontario, Canada|
|Principal Investigator: Venkatesh Thiruganasambandamoorthy, MD|
|Niagara Health||Not yet recruiting|
|St. Catharines, Ontario, Canada, L2S 0A9|
|Principal Investigator: Lucas Ciprietti, MD|
|St. Joseph's Health Centre||Not yet recruiting|
|Toronto, Ontario, Canada, M6R1B5|
|Principal Investigator: Mark Unger, MD|